Candel Therapeutics CADL
NASDAQ CADL
$10.18 +0.02 (+0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Candel Therapeutics (CADL) Price to Sales (2021 - 2022)

Updated

Candel Therapeutics' Price to Sales came in at 417.47 for Q4 2022, down 64.9% from 1190.22 a year earlier and down 42.9% from the prior quarter.

Analysis

Candel Therapeutics (CADL) Price to Sales (2021 - 2022) Analysis & Trends

For FY2022, Candel Therapeutics' Price to Sales was 414.13, down 64.9% from FY2021.

  • Going back by year, Price to Sales was 1180.70 in FY2021.
  • Business Quant data shows CADL's Price to Sales at 731.62 (Q3 2022), 754.92 (Q2 2022) and 1177.81 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Candel Therapeutics 774.88 Mn 774.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 417.47
Sep 30, 2022 731.62
Jun 30, 2022 754.92
Mar 31, 2022 1,177.81
Dec 31, 2021 1,190.22
Sep 30, 2021 2,039.12
API Access

Candel Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CADL&period=max&api_key=YOUR_API_KEY